Abstract
Chemoprevention is an attempt to use either naturally occurring or synthetic substances or their mixtures to intervene in the progress of carcinogenesis. Recently, it has been shown that green tea phytochemicals alter gene expression, directly or indirectly, thereby regulating the carcinogenic processes. Epigallocatechin-3-gallate (EGCG), the major antioxidant polyphenolic compound present in green tea, is a promising chemopreventive agent. EGCG has been shown to exert growth-inhibitory potential of various cancer cells in culture and antitumor activity in vivo models. EGCG could interact with various molecules like proteins, transcription factors, and enzymes, which block multiple stages of carcinogenesis. Moreover, much of the cancer chemopreventive effects of EGCG that regulates cell proliferation and apoptosis effects by altering the expression of cell cycle regulatory proteins, activating killer caspases, induction of phase II enzymes, mediation of anti-oxidative, anti-inflammation responses, and suppressing oncogenic transcription factors and pluripotency maintain factors. In vitro and in vivo studies have demonstrated that EGCG blocks carcinogenesis by affecting a wide array of signal transduction pathways involved in cell proliferation, transformation, inflammation, apoptosis, metastasis and invasion. EGCG stimulates telomere fragmentation through inhibiting telomerase activity. Recent reports demonstrated that EGCG inhibits DNA methyltransferases, proteases, and dihydrofolate reductase activities, which would affect transcription of tumor suppressor genes and protein synthesis. To develop EGCG as an anticarcinogenic agent, more clear understanding of the cell signaling pathways and the molecular targets responsible for chemopreventive and chemotherapeutic effects are needed. This review summarizes recent preclinical and clinical research on the EGCG-induced cellular signal transduction events which implicate in prevention and therapy of cancer.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- α-TNF:
-
Alpha-tumor necrosis factor
- AMPK:
-
Adenosine monophosphate-activated protein kinase
- AP1:
-
Activator protein 1
- AREs:
-
Antioxidant responsive elements
- Bcl-2:
-
B-cell lymphoma-2
- CAT:
-
Catalase
- CDKN2A:
-
Cyclin dependent kinase 2A
- Cdks:
-
Cyclin-dependent kinases
- c-IAP1:
-
Cellular inhibitor of apoptosis protein1
- COX-2:
-
Cyclooxygenase-2
- CpG:
-
Cytosine-phosphate-guanine
- CSCs:
-
Cancer stem cells
- CYP:
-
Cytochrome P450
- DHFR:
-
Dihydrofolate reductase
- DIABLO:
-
Direct inhibitor of apoptosis-binding protein with low pI
- DNMTs:
-
DNA methyltransferases
- EGCG:
-
(-)-Epigallocatechin-3-gallate
- EGFR:
-
Epidermal growth factor receptor
- EpRE:
-
Electrophile-responsive element
- ERK:
-
Extracellular signal-regulated kinase
- FAK:
-
Focal adhesion kinase
- FKHR:
-
Forkhead homolog of rhabdosarcoma
- GFRs:
-
Growth factor receptors
- GPx:
-
Glutathione peroxidase
- GR:
-
Glutathione reductase
- GST:
-
Glutathione S-transferase
- H2O2 :
-
Hydrogen peroxide
- HATs:
-
Histone acetyl transferases
- HDACs:
-
Histone deacetylases
- HER:
-
Human epidermal receptor
- HIF:
-
Hypoxia inducible factor
- hTERT:
-
human telomerase reverse transcriptase
- HUVEC:
-
Human vascular endothelial cell
- IKK:
-
I kappa B kinase
- IL-1:
-
Interleukin 1
- JNK:
-
Jun NH2-terminal kinase
- LPs:
-
Lipopolysaccharides
- MAP:
-
Mitogen-activated protein
- MBD:
-
Methyl-CpG binding domain
- Mcl-1:
-
Myeloid cell leukemia 1
- mdm2:
-
mouse double minute 2
- MEKK1:
-
Mitogen-activated protein/ERK kinase 1
- MLH1:
-
MutL homologue 1
- MMPs:
-
Matrix metalloproteinases
- MRLC:
-
Myosin regulatory light chain
- MT1-MMP:
-
Membrane Type 1-matrix metalloproteinase
- NFκB:
-
Nuclear factor kappaB
- NQO:
-
NADPH quinone oxidoreductase
- Nrf:
-
NF-E2 p45-related factor
- O •−2 :
-
Superoxide anion radical
- •OH:
-
Hydroxyl radical
- p90RSK:
-
90 kDa ribosomal S6 kinase
- PCNA:
-
Proliferating cell nuclear antigen
- PDGF:
-
Platelet-derived growth factor
- PGE2:
-
Prostaglandins E2
- PI3K:
-
Phosphatidylinositol- 3-kinase
- PKA:
-
Protein kinase A
- PPAR:
-
Peroxisome proliferator-activated receptor
- pRb:
-
Retinoblastoma protein
- PUMA:
-
P53 upregulated modulator of apoptosis
- RAR:
-
Retinoic acid receptor
- RECK:
-
Reversion-inducing cysteine-rich protein with Kazal motifs
- RTK:
-
Receptor tyrosine kinase
- RXRα:
-
Retinoid X receptor alpha
- SAM:
-
S-adenosyl-methionine
- siRNA:
-
Small-interfering RNA
- Smac:
-
Second mitochondria-derived activator of caspase
- SOD:
-
Superoxide dismutase
- STAT:
-
Signal transducers and activators of transcription
- TERT:
-
Telomerase reverse transcriptase
- TIMP:
-
Tissue inhibitor of metalloproteinase
- TRAIL:
-
Tumor necrosis factor-related apoptosis-inducing ligand
- TRAMP:
-
Transgenic adenocarcinoma of the mouse prostate
- TSGs:
-
Tumor suppressor genes
- uPA:
-
Urokinase plasminogen activator
- VEGF:
-
Vascular endothelial growth factor
- XIAP:
-
X-linked inhibitor of apoptosis protein
References
Adams J, Kauffman M (2004) Development of the proteasome inhibitor Velcade (Bortezomib). Cancer Invest 22:304–311
Adhami VM, Siddiqui IA, Ahmad N, Gupta S, Mukhtar H (2004) Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer. Cancer Res 64:8715–8722
Afaq F, Adhami VM, Ahmad N, Mukhtar H (2003a) Inhibition of ultraviolet B-mediated activation of nuclear factor kappaB in normal human epidermal keratinocytes by green tea Constituent (-)-epigallocatechin-3-gallate. Oncogene 22:1035–1044
Afaq F, Ahmad N, Mukhtar H (2003b) Suppression of UVB-induced phosphorylation of mitogen-activated protein kinases and nuclear factor kappa B by green tea polyphenol in SKH-1 hairless mice. Oncogene 22:9254–9264
Aggarwal BB, Shishodia S (2006) Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 71:1397–1421
Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, Takada Y (2004) Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res 24:2783–2840
Ahmad N, Feyes DK, Nieminen AL, Agarwal R, Mukhtar H (1997) Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J Natl Cancer Inst 89:1881–1886
Ahmad N, Adhami VM, Gupta S, Cheng P, Mukhtar H (2002) Role of the retinoblastoma (pRb)-E2F/DP pathway in cancer chemopreventive effects of green tea polyphenol epigallocatechin-3-gallate. Arch Biochem Biophys 398:125–131
Ahmed S (2010) Green tea polyphenol epigallocatechin 3-gallate in arthritis: progress and promise. Arthritis Res Ther 12:208
Ahmed S, Wang N, Lalonde M, Goldberg VM, Haqqi TM (2004) Green tea polyphenol epigallocatechin-3-gallate (EGCG) differentially inhibits interleukin-1 beta-induced expression of matrix metalloproteinase-1 and -13 in human chondrocytes. J Pharmacol Exp Ther 308:767–773
Ahn WS, Huh SW, Bae SM, Lee IP, Lee JM, Namkoong SE, Kim CK, Sin JI (2003a) A major constituent of green tea, EGCG, inhibits the growth of a human cervical cancer cell line, CaSki cells, through apoptosis, G(1) arrest, and regulation of gene expression. DNA Cell Biol 22:217–224
Ahn WS, Yoo J, Huh SW, Kim CK, Lee JM, Namkoong SE, Bae SM, Lee IP (2003b) Protective effects of green tea extracts (polyphenon E and EGCG) on human cervical lesions. Eur J Cancer Prev 12:383–390
Anton S, Melville L, Rena G (2007) Epigallocatechin gallate (EGCG) mimics insulin action on the transcription factor FOXO1a and elicits cellular responses in the presence and absence of insulin. Cell Signal 19:378–383
Artandi SE (2002) Telomere shortening and cell fates in mouse models of neoplasia. Trends Mol Med 8:44–47
Babich H, Zuckerbraun HL, Weinerman SM (2007) In vitro cytotoxicity of (-)-catechin gallate, a minor polyphenol in green tea. Toxicol Lett 171:171–180
Babu PV, Sabitha KE, Shyamaladevi CS (2006) Therapeutic effect of green tea extract on oxidative stress in aorta and heart of streptozotocin diabetic rats. Chem Biol Interact 162:114–120
Bakiri L, Lallemand D, Bossy-Wetzel E, Yaniv M (2000) Cell cycle-dependent variations in c-Jun and JunB phosphorylation: a role in the control of cyclin D1 expression. EMBO J 19:2056–2068
Barber CG, Dickinson RP, Fish PV (2004) Selective urokinase-type plasminogen activator (uPA) inhibitors. Part 3: 1-isoquinolinylguanidines. Bioorg Med Chem Lett 14:3227–3230
Bartholome A, Kampkotter A, Tanner S, Sies H, Klotz LO (2010) Epigallocatechin gallate-induced modulation of FoxO signaling in mammalian cells and C. elegans: FoxO stimulation is masked via PI3K/Akt activation by hydrogen peroxide formed in cell culture. Arch Biochem Biophys 501:58–64
Berger SJ, Gupta S, Belfi CA, Gosky DM, Mukhtar H (2001) Green tea constituent (–)-epigallocatechin-3-gallate inhibits topoisomerase I activity in human colon carcinoma cells. Biochem Biophys Res Commun 288:101–105
Bettuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G, Corti A (2006) Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Cancer Res 66:1234–1240
Campbell KJ, O’Shea JM, Perkins ND (2006) Differential regulation of NF-kappaB activation and function by topoisomerase II inhibitors. BMC Cancer 6:101
Chacko SM, Thambi PT, Kuttan R, Nishigaki I (2010) Beneficial effects of green tea: a literature review. Chin Med 5:13
Chan HY, Wang H, Tsang DS, Chen ZY, Leung LK (2003) Screening of chemopreventive tea polyphenols against PAH genotoxicity in breast cancer cells by a XRE-luciferase reporter construct. Nutr Cancer 46:93–100
Chandra S, De Mejia GE (2004) Polyphenolic compounds, antioxidant capacity, and quinone reductase activity of an aqueous extract of Ardisia compressa in comparison to mate (Ilex paraguariensis) and green (Camellia sinensis) teas. J Agric Food Chem 52:3583–3589
Chen Z, Zhu QY, Tsang D, Huang Y (2001) Degradation of green tea catechins in tea drinks. J Agric Food Chem 49:477–482
Chen Q, Ganapathy S, Singh KP, Shankar S, Srivastava RK (2010a) Resveratrol induces growth arrest and apoptosis through activation of FOXO transcription factors in prostate cancer cells. PLoS One 5:e15288
Chen X, Lu W, Zheng Y, Gu K, Chen Z, Zheng W, Shu XO (2010b) Exercise, tea consumption, and depression among breast cancer survivors. J Clin Oncol 28:991–998
Chen NG, Lu CC, Lin YH, Shen WC, Lai CH, Ho YJ, Chung JG, Lin TH, Lin YC, Yang JS (2011) Proteomic approaches to study epigallocatechin gallate-provoked apoptosis of TSGH-8301 human urinary bladder carcinoma cells: roles of AKT and heat shock protein 27-modulated intrinsic apoptotic pathways. Oncol Rep 26:939–947
Choi JH, Rhee IK, Park KY, Kim JK, Rhee SJ (2003) Action of green tea catechin on bone metabolic disorder in chronic cadmium-poisoned rats. Life Sci 73:1479–1489
Chuang JC, Yoo CB, Kwan JM, Li TW, Liang G, Yang AS, Jones PA (2005) Comparison of biological effects of non-nucleoside DNA methylation inhibitors versus 5-aza-2′-deoxycytidine. Mol Cancer Ther 4:1515–1520
Ciechanover A (1994) The ubiquitin-proteasome proteolytic pathway. Cell 79:13–21
Croce CM (2009) Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 10:704–714
Croce CM, Calin GA (2005) miRNAs, cancer, and stem cell division. Cell 122:6–7
Dong Z, Ma W, Huang C, Yang CS (1997) Inhibition of tumor promoter-induced activator protein 1 activation and cell transformation by tea polyphenols, (-)-epigallocatechin gallate, and theaflavins. Cancer Res 57:4414–4419
Eferl R, Wagner EF (2003) AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer 3:859–868
Fang MZ, Wang Y, Ai N, Hou Z, Sun Y, Lu H, Welsh W, Yang CS (2003) Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res 63:7563–7570
Fang JY, Tsai TH, Lin YY, Wong WW, Wang MN, Huang JF (2007) Transdermal delivery of tea catechins and theophylline enhanced by terpenes: a mechanistic study. Biol Pharm Bull 30:343–349
Folkman J (2002) Role of angiogenesis in tumor growth and metastasis. Semin Oncol 29:15–18
Fujiki H, Suganuma M, Okabe S, Sueoka E, Suga K, Imai K, Nakachi K, Kimura S (1999) Mechanistic findings of green tea as cancer preventive for humans. Proc Soc Exp Biol Med 220:225–228
Fujiki H, Suganuma M, Okabe S, Sueoka E, Sueoka N, Fujimoto N, Goto Y, Matsuyama S, Imai K, Nakachi K (2001) Cancer prevention with green tea and monitoring by a new biomarker, hnRNP B1. Mutat Res 480–481:299–304
Fujita Y, Yamane T, Tanaka M, Kuwata K, Okuzumi J, Takahashi T, Fujiki H, Okuda T (1989) Inhibitory effect of (-)-epigallocatechin gallate on carcinogenesis with N-ethyl-N′-nitro-N-nitrosoguanidine in mouse duodenum. Jpn J Cancer Res 80:503–505
Galluzzi L, Morselli E, Vitale I, Kepp O, Senovilla L, Criollo A, Servant N, Paccard C, Hupe P, Robert T, Ripoche H, Lazar V, Harel-Bellan A, Dessen P, Barillot E, Kroemer G (2010) miR-181a and miR-630 regulate cisplatin-induced cancer cell death. Cancer Res 70:1793–1803
Gerhauser C, Klimo K, Heiss E, Neumann I, Gamal-Eldeen A, Knauft J, Liu GY, Sitthimonchai S, Frank N (2003) Mechanism-based in vitro screening of potential cancer chemopreventive agents. Mutat Res 523–524:163–172
Givant-Horwitz V, Davidson B, Reich R (2004) Laminin-induced signaling in tumor cells: the role of the M(r) 67,000 laminin receptor. Cancer Res 64:3572–3579
Guo S, Yang S, Taylor C, Sonenshein GE (2005) Green tea polyphenol epigallocatechin-3 gallate (EGCG) affects gene expression of breast cancer cells transformed by the carcinogen 7,12-dimethylbenz[a]anthracene. J Nutr 135:2978S–2986S
Gupta S, Hussain T, Mukhtar H (2003) Molecular pathway for (-)-epigallocatechin-3-gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cells. Arch Biochem Biophys 410:177–185
Gupta S, Hastak K, Afaq F, Ahmad N, Mukhtar H (2004) Essential role of caspases in epigallocatechin-3-gallate-mediated inhibition of nuclear factor kappa B and induction of apoptosis. Oncogene 23:2507–2522
Hastak K, Gupta S, Ahmad N, Agarwal MK, Agarwal ML, Mukhtar H (2003) Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells. Oncogene 22:4851–4859
Herbst RS (2004) Review of epidermal growth factor receptor biology. Int J Radiat Oncol Biol Phys 59:21–26
Hibasami H, Achiwa Y, Fujikawa T, Komiya T (1996) Induction of programmed cell death (apoptosis) in human lymphoid leukemia cells by catechin compounds. Anticancer Res 16:1943–1946
Higdon JV, Frei B (2003) Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit Rev Food Sci Nutr 43:89–143
Hou Z, Lambert JD, Chin KV, Yang CS (2004) Effects of tea polyphenols on signal transduction pathways related to cancer chemoprevention. Mutat Res 555:3–19
Hsu YC, Liou YM (2011) The anti-cancer effects of (-)-epigalocathine-3-gallate on the signaling pathways associated with membrane receptors in MCF-7 cells. J Cell Physiol 226:2721–2730
Hu J, Zhou D, Chen Y (2009) Preparation and antioxidant activity of green tea extract enriched in epigallocatechin (EGC) and epigallocatechin gallate (EGCG). J Agric Food Chem 57:1349–1353
Huang CC, Wu WB, Fang JY, Chiang HS, Chen SK, Chen BH, Chen YT, Hung CF (2007) (-)-Epicatechin-3-gallate, a green tea polyphenol is a potent agent against UVB-induced damage in HaCaT keratinocytes. Molecules 12:1845–1858
Hussain T, Gupta S, Adhami VM, Mukhtar H (2005) Green tea constituent epigallocatechin-3-gallate selectively inhibits COX-2 without affecting COX-1 expression in human prostate carcinoma cells. Int J Cancer 113:660–669
Jankun J, Selman SH, Swiercz R, Skrzypczak-Jankun E (1997) Why drinking green tea could prevent cancer. Nature 387:561
Jeong WS, Kim IW, Hu R, Kong AN (2004) Modulatory properties of various natural chemopreventive agents on the activation of NF-kappaB signaling pathway. Pharm Res 21:661–670
Ju J, Hong J, Zhou JN, Pan Z, Bose M, Liao J, Yang GY, Liu YY, Hou Z, Lin Y, Ma J, Shih WJ, Carothers AM, Yang CS (2005) Inhibition of intestinal tumorigenesis in Apcmin/+ mice by (-)-epigallocatechin-3-gallate, the major catechin in green tea. Cancer Res 65:10623–10631
Katiyar SK, Mukhtar H (1996) Tea consumption and cancer. World Rev Nutr Diet 79:154–184
Katiyar SK, Agarwal R, Zaim MT, Mukhtar H (1993) Protection against N-nitrosodiethylamine and benzo[a]pyrene-induced forestomach and lung tumorigenesis in A/J mice by green tea. Carcinogenesis 14:849–855
Kato K, Long NK, Makita H, Toida M, Yamashita T, Hatakeyama D, Hara A, Mori H, Shibata T (2008) Effects of green tea polyphenol on methylation status of RECK gene and cancer cell invasion in oral squamous cell carcinoma cells. Br J Cancer 99:647–654
Khafif A, Schantz SP, Chou TC, Edelstein D, Sacks PG (1998) Quantitation of chemopreventive synergism between (-)-epigallocatechin-3-gallate and curcumin in normal, premalignant and malignant human oral epithelial cells. Carcinogenesis 19:419–424
Khan N, Mukhtar H (2010) Cancer and metastasis: prevention and treatment by green tea. Cancer Metastasis Rev 29:435–445
Khan N, Afaq F, Saleem M, Ahmad N, Mukhtar H (2006) Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. Cancer Res 66:2500–2505
Khan N, Adhami VM, Mukhtar H (2010) Apoptosis by dietary agents for prevention and treatment of prostate cancer. Endocr Relat Cancer 17:R39–R52
Kim HJ, Yum KS, Sung JH, Rhie DJ, Kim MJ, Min DS, Hahn SJ, Kim MS, Jo YH, Yoon SH (2004a) Epigallocatechin-3-gallate increases intracellular [Ca2+] in U87 cells mainly by influx of extracellular Ca2+ and partly by release of intracellular stores. Naunyn Schmiedebergs Arch Pharmacol 369:260–267
Kim HS, Kim MH, Jeong M, Hwang YS, Lim SH, Shin BA, Ahn BW, Jung YD (2004b) EGCG blocks tumor promoter-induced MMP-9 expression via suppression of MAPK and AP-1 activation in human gastric AGS cells. Anticancer Res 24:747–753
Kotani A, Ha D, Hsieh J, Rao PK, Schotte D, den Boer ML, Armstrong SA, Lodish HF (2009) miR-128b is a potent glucocorticoid sensitizer in MLL-AF4 acute lymphocytic leukemia cells and exerts cooperative effects with miR-221. Blood 114:4169–4178
Kumaran G, Clamp AR, Jayson GC (2008) Angiogenesis as a therapeutic target in cancer. Clin Med 8:455–458
Kundu JK, Na HK, Chun KS, Kim YK, Lee SJ, Lee SS, Lee OS, Sim YC, Surh YJ (2003) Inhibition of phorbol ester-induced COX-2 expression by epigallocatechin gallate in mouse skin and cultured human mammary epithelial cells. J Nutr 133:3805S–3810S
Lambert JD, Elias RJ (2010) The antioxidant and pro-oxidant activities of green tea polyphenols: a role in cancer prevention. Arch Biochem Biophys 501:65–72
Lambert JD, Yang CS (2003) Mechanisms of cancer prevention by tea constituents. J Nutr 133:3262S–3267S
Lambert JD, Rice JE, Hong J, Hou Z, Yang CS (2005) Synthesis and biological activity of the tea catechin metabolites, M4 and M6 and their methoxy-derivatives. Bioorg Med Chem Lett 15:873–876
Lee MJ, Prabhu S, Meng X, Li C, Yang CS (2000) An improved method for the determination of green and black tea polyphenols in biomatrices by high-performance liquid chromatography with coulometric array detection. Anal Biochem 279:164–169
Lee KM, Yeo M, Choue JS, Jin JH, Park SJ, Cheong JY, Lee KJ, Kim JH, Hahm KB (2004) Protective mechanism of epigallocatechin-3-gallate against Helicobacter pylori-induced gastric epithelial cytotoxicity via the blockage of TLR-4 signaling. Helicobacter 9:632–642
Lee WJ, Shim JY, Zhu BT (2005) Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids. Mol Pharmacol 68:1018–1030
Lee JH, Shim JS, Lee JS, Kim JK, Yang IS, Chung MS, Kim KH (2006) Inhibition of pathogenic bacterial adhesion by acidic polysaccharide from green tea (Camellia sinensis). J Agric Food Chem 54:8717–8723
Lim YC, Cha YY (2011) Epigallocatechin-3-gallate induces growth inhibition and apoptosis of human anaplastic thyroid carcinoma cells through suppression of EGFR/ERK pathway and cyclin B1/CDK1 complex. J Surg Oncol 104(7):776–780
Lin JK (2002) Cancer chemoprevention by tea polyphenols through modulating signal transduction pathways. Arch Pharm Res 25:561–571
Lin YL, Lin JK (1997) (-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-kappaB. Mol Pharmacol 52:465–472
Lin SM, Wang SW, Ho SC, Tang YL (2010) Protective effect of green tea (-)-epigallocatechin-3-gallate against the monoamine oxidase B enzyme activity increase in adult rat brains. Nutrition 26:1195–1200
Liu TT, Liang NS, Li Y, Yang F, Lu Y, Meng ZQ, Zhang LS (2003) Effects of long-term tea polyphenols consumption on hepatic microsomal drug-metabolizing enzymes and liver function in Wistar rats. World J Gastroenterol 9:2742–2744
Lopez-Lazaro M, Calderon-Montano JM, Burgos-Moron E, Austin CA (2011) Green tea constituents (-)-epigallocatechin-3-gallate (EGCG) and gallic acid induce topoisomerase I- and topoisomerase II-DNA complexes in cells mediated by pyrogallol-induced hydrogen peroxide. Mutagenesis 26(4):489–498
Lu YP, Lou YR, Lin Y, Shih WJ, Huang MT, Yang CS, Conney AH (2001) Inhibitory effects of orally administered green tea, black tea, and caffeine on skin carcinogenesis in mice previously treated with ultraviolet B light (high-risk mice): relationship to decreased tissue fat. Cancer Res 61:5002–5009
Majima T, Tsutsumi M, Nishino H, Tsunoda T, Konishi Y (1998) Inhibitory effects of beta-carotene, palm carotene, and green tea polyphenols on pancreatic carcinogenesis initiated by N-nitorsobis(2-oxopropyl)amine in Syrian golden hamsters. Pancreas 16:13–18
Maliakal PP, Coville PF, Wanwimolruk S (2001) Tea consumption modulates hepatic drug metabolizing enzymes in Wistar rats. J Pharm Pharmacol 53:569–577
Manson MM (2003) Cancer prevention – the potential for diet to modulate molecular signalling. Trends Mol Med 9:11–18
Masamune A, Kikuta K, Satoh M, Suzuki N, Shimosegawa T (2005) Green tea polyphenol epigallocatechin-3-gallate blocks PDGF-induced proliferation and migration of rat pancreatic stellate cells. World J Gastroenterol 11:3368–3374
Masuda M, Suzui M, Weinstein IB (2001) Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines. Clin Cancer Res 7:4220–4229
Masuda M, Suzui M, Lim JT, Deguchi A, Soh JW, Weinstein IB (2002) Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction. J Exp Ther Oncol 2:350–359
Masuda M, Suzui M, Lim JT, Weinstein IB (2003) Epigallocatechin-3-gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells. Clin Cancer Res 9:3486–3491
Masuda M, Wakasaki T, Toh S, Shimizu M, Adachi S (2011) Chemoprevention of head and neck cancer by green tea extract: EGCG-the role of EGFR signaling and “Lipid Raft”. J Oncol 2011:540148
Meeran SM, Mantena SK, Elmets CA, Katiyar SK (2006) (-)-Epigallocatechin-3-gallate prevents photocarcinogenesis in mice through interleukin-12-dependent DNA repair. Cancer Res 66:5512–5520
Milligan SA, Burke P, Coleman DT, Bigelow RL, Steffan JJ, Carroll JL, Williams BJ, Cardelli JA (2009) The green tea polyphenol EGCG potentiates the antiproliferative activity of c-Met and epidermal growth factor receptor inhibitors in non-small cell lung cancer cells. Clin Cancer Res 15:4885–4894
Morissette M, Samadi P, Hadj Tahar A, Belanger N, Di Paolo T (2010) Striatal Akt/GSK3 signaling pathway in the development of L-Dopa-induced dyskinesias in MPTP monkeys. Prog Neuropsychopharmacol Biol Psychiatry 34:446–454
Mukhtar H, Ahmad N (2000) Tea polyphenols: prevention of cancer and optimizing health. Am J Clin Nutr 71:1698S–1702S, discussion 1703S–1694S
Murakami C, Hirakawa Y, Inui H, Nakano Y, Yoshida H (2002) Effect of tea catechins on cellular lipid peroxidation and cytotoxicity in HepG2 cells. Biosci Biotechnol Biochem 66:1559–1562
Muzolf-Panek M, Gliszczynska-Swiglo A, de Haan L, Aarts JM, Szymusiak H, Vervoort JM, Tyrakowska B, Rietjens IM (2008) Role of catechin quinones in the induction of EpRE-mediated gene expression. Chem Res Toxicol 21:2352–2360
Naasani I, Seimiya H, Tsuruo T (1998) Telomerase inhibition, telomere shortening, and senescence of cancer cells by tea catechins. Biochem Biophys Res Commun 249:391–396
Nakae J, Biggs WH 3rd, Kitamura T, Cavenee WK, Wright CV, Arden KC, Accili D (2002) Regulation of insulin action and pancreatic beta-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1. Nat Genet 32:245–253
Nam S, Smith DM, Dou QP (2001) Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo. J Biol Chem 276:13322–13330
Nandakumar V, Vaid M, Katiyar SK (2011) (-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells. Carcinogenesis 32(4):537–544
Narisawa T, Fukaura Y (1993) A very low dose of green tea polyphenols in drinking water prevents N-methyl-N-nitrosourea-induced colon carcinogenesis in F344 rats. Jpn J Cancer Res 84:1007–1009
Navarro-Martinez MD, Navarro-Peran E, Cabezas-Herrera J, Ruiz-Gomez J, Garcia-Canovas F, Rodriguez-Lopez JN (2005) Antifolate activity of epigallocatechin gallate against Stenotrophomonas maltophilia. Antimicrob Agents Chemother 49:2914–2920
Newton K, Strasser A (2000) Ionizing radiation and chemotherapeutic drugs induce apoptosis in lymphocytes in the absence of Fas or FADD/MORT1 signaling. Implications for cancer therapy. J Exp Med 191:195–200
Oku N, Matsukawa M, Yamakawa S, Asai T, Yahara S, Hashimoto F, Akizawa T (2003) Inhibitory effect of green tea polyphenols on membrane-type 1 matrix metalloproteinase, MT1-MMP. Biol Pharm Bull 26:1235–1238
Plass C, Soloway PD (2002) DNA methylation, imprinting and cancer. Eur J Hum Genet 10:6–16
Plumb GW, Price KR, Williamson G (1999) Antioxidant properties of flavonol glycosides from tea. Redox Rep 4:13–16
Prakash D, Suri S, Upadhyay G, Singh BN (2007) Total phenol, antioxidant and free radical scavenging activities of some medicinal plants. Int J Food Sci Nutr 58:18–28
Reiter CE, Kim JA, Quon MJ (2010) Green tea polyphenol epigallocatechin gallate reduces endothelin-1 expression and secretion in vascular endothelial cells: roles for AMP-activated protein kinase, Akt, and FOXO1. Endocrinology 151:103–114
Rietveld A, Wiseman S (2003) Antioxidant effects of tea: evidence from human clinical trials. J Nutr 133:3285S–3292S
Rose BA, Force T, Wang Y (2010) Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale. Physiol Rev 90:1507–1546
Roy SK, Srivastava RK, Shankar S (2010) Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer. J Mol Signal 5:10
Sanchez-Huerta V, Gutierrez-Sanchez L, Flores-Estrada J (2011) (-)-Epigallocatechin 3-gallate (EGCG) at the ocular surface inhibits corneal neovascularization. Med Hypotheses 76:311–313
Sartippour MR, Shao ZM, Heber D, Beatty P, Zhang L, Liu C, Ellis L, Liu W, Go VL, Brooks MN (2002) Green tea inhibits vascular endothelial growth factor (VEGF) induction in human breast cancer cells. J Nutr 132:2307–2311
Sazuka M, Itoi T, Suzuki Y, Odani S, Koide T, Isemura M (1996) Evidence for the interaction between (-)-epigallocatechin gallate and human plasma proteins fibronectin, fibrinogen, and histidine-rich glycoprotein. Biosci Biotechnol Biochem 60:1317–1319
Schwarz RE, Donohue CA, Sadava D, Kane SE (2003) Pancreatic cancer in vitro toxicity mediated by Chinese herbs SPES and PC-SPES: implications for monotherapy and combination treatment. Cancer Lett 189:59–68
Senthil Kumaran V, Arulmathi K, Srividhya R, Kalaiselvi P (2008) Repletion of antioxidant status by EGCG and retardation of oxidative damage induced macromolecular anomalies in aged rats. Exp Gerontol 43:176–183
Sergediene E, Jonsson K, Szymusiak H, Tyrakowska B, Rietjens IM, Cenas N (1999) Prooxidant toxicity of polyphenolic antioxidants to HL-60 cells: description of quantitative structure-activity relationships. FEBS Lett 462:392–396
Shankar S, Suthakar G, Srivastava RK (2007) Epigallocatechin-3-gallate inhibits cell cycle and induces apoptosis in pancreatic cancer. Front Biosci 12:5039–5051
Shankar S, Chen Q, Srivastava RK (2008a) Inhibition of PI3K/AKT and MEK/ERK pathways act synergistically to enhance antiangiogenic effects of EGCG through activation of FOXO transcription factor. J Mol Signal 3:7
Shankar S, Ganapathy S, Hingorani SR, Srivastava RK (2008b) EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer. Front Biosci 13:440–452
Shankar S, Nall D, Tang SN, Meeker D, Passarini J, Sharma J, Srivastava RK (2011) Resveratrol inhibits pancreatic cancer stem cell characteristics in human and KrasG12D transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transition. PLoS One 6:e16530
Sharpless NE, DePinho RA (2004) Telomeres, stem cells, senescence, and cancer. J Clin Invest 113:160–168
Shimizu M, Weinstein IB (2005) Modulation of signal transduction by tea catechins and related phytochemicals. Mutat Res 591:147–160
Shimizu M, Deguchi A, Lim JT, Moriwaki H, Kopelovich L, Weinstein IB (2005) (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells. Clin Cancer Res 11:2735–2746
Siddiqui IA, Asim M, Hafeez BB, Adhami VM, Tarapore RS, Mukhtar H (2010) Green tea polyphenol EGCG blunts androgen receptor function in prostate cancer. FASEB J 25(4):1098–1207
Sigler K, Ruch RJ (1993) Enhancement of gap junctional intercellular communication in tumor promoter-treated cells by components of green tea. Cancer Lett 69:15–19
Silverman N, Maniatis T (2001) NF-kappaB signaling pathways in mammalian and insect innate immunity. Genes Dev 15:2321–2342
Singh BN, Singh BR, Singh RL, Prakash D, Dhakarey R, Upadhyay G, Singh HB (2009a) Oxidative DNA damage protective activity, antioxidant and anti-quorum sensing potentials of Moringa oleifera. Food Chem Toxicol 47:1109–1116
Singh BN, Singh BR, Singh RL, Prakash D, Sarma BK, Singh HB (2009b) Antioxidant and anti-quorum sensing activities of green pod of Acacia nilotica L. Food Chem Toxicol 47:778–786
Singh BN, Singh BR, Singh RL, Prakash D, Singh DP, Sarma BK, Upadhyay G, Singh HB (2009c) Polyphenolics from various extracts/fractions of red onion (Allium cepa) peel with potent antioxidant and antimutagenic activities. Food Chem Toxicol 47:1161–1167
Singh BN, Singh BR, Singh RL, Prakash D, Singh DP, Sarma BK, Upadhyay G, Singh HB (2009d) Polyphenolics from various extracts/fractions of red onion (Allium cepa) peel with potential antioxidant and antimutagenic activities. Food Chem Toxicol
Singh BN, Zhang G, Hwa YL, Li J, Dowdy SC, Jiang SW (2010a) Nonhistone protein acetylation as cancer therapy targets. Expert Rev Anticancer Ther 10:935–954
Singh HB, Singh BN, Singh SP, Nautiyal CS (2010b) Solid-state cultivation of Trichoderma harzianum NBRI-1055 for modulating natural antioxidants in soybean seed matrix. Bioresour Technol 101:6444–6453
Singh M, Tyagi S, Bhui K, Prasad S, Shukla Y (2010c) Regulation of cell growth through cell cycle arrest and apoptosis in HPV 16 positive human cervical cancer cells by tea polyphenols. Invest New Drugs 28:216–224
Singh BN, Shankar S, Srivastava RK (2011) Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochem Pharmacol 82(12):1807–1821
Smith DM, Wang Z, Kazi A, Li LH, Chan TH, Dou QP (2002) Synthetic analogs of green tea polyphenols as proteasome inhibitors. Mol Med 8:382–392
Sonee M, Sum T, Wang C, Mukherjee SK (2004) The soy isoflavone, genistein, protects human cortical neuronal cells from oxidative stress. Neurotoxicology 25:885–891
Srivastava RK, Unterman TG, Shankar S (2010) FOXO transcription factors and VEGF neutralizing antibody enhance antiangiogenic effects of resveratrol. Mol Cell Biochem 337:201–212
Srividhya R, Jyothilakshmi V, Arulmathi K, Senthilkumaran V, Kalaiselvi P (2008) Attenuation of senescence-induced oxidative exacerbations in aged rat brain by (-)-epigallocatechin-3-gallate. Int J Dev Neurosci 26:217–223
Subbaramaiah K, Dannenberg AJ (2003) Cyclooxygenase 2: a molecular target for cancer prevention and treatment. Trends Pharmacol Sci 24:96–102
Surh YJ (2003) Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 3:768–780
Suzuki H, Tokino T, Shinomura Y, Imai K, Toyota M (2008) DNA methylation and cancer pathways in gastrointestinal tumors. Pharmacogenomics 9:1917–1928
Syed DN, Afaq F, Kweon MH, Hadi N, Bhatia N, Spiegelman VS, Mukhtar H (2007) Green tea polyphenol EGCG suppresses cigarette smoke condensate-induced NF-kappaB activation in normal human bronchial epithelial cells. Oncogene 26:673–682
Tachibana H, Fujimura Y, Yamada K (2004) Tea polyphenol epigallocatechin-3-gallate associates with plasma membrane lipid rafts: lipid rafts mediate anti-allergic action of the catechin. Biofactors 21:383–385
Tamura K, Nakae D, Horiguchi K, Akai H, Kobayashi Y, Satoh H, Tsujiuchi T, Denda A, Konishi Y (1997) Inhibition by green tea extract of diethylnitrosamine-initiated but not choline-deficient, L-amino acid-defined diet-associated development of putative preneoplastic, glutathione S-transferase placental form-positive lesions in rat liver. Jpn J Cancer Res 88:356–362
Tang GQ, Yan TQ, Guo W, Ren TT, Peng CL, Zhao H, Lu XC, Zhao FL, Han X (2010a) (-)-Epigallocatechin-3-gallate induces apoptosis and suppresses proliferation by inhibiting the human Indian Hedgehog pathway in human chondrosarcoma cells. J Cancer Res Clin Oncol 136:1179–1185
Tang SN, Singh C, Nall D, Meeker D, Shankar S, Srivastava RK (2010b) The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition. J Mol Signal 5:14
Tang SN, Fu J, Nall D, Rodova M, Shankar S, Srivastava RK (2011) Inhibition of sonic hedgehog pathway and pluripotency maintaining factors regulate human pancreatic cancer stem cell characteristics. Int J Cancer
Teng B, Qin W, Ansari HR, Mustafa SJ (2005) Involvement of p38-mitogen-activated protein kinase in adenosine receptor-mediated relaxation of coronary artery. Am J Physiol Heart Circ Physiol 288:H2574–H2580
Thawonsuwan J, Kiron V, Satoh S, Panigrahi A, Verlhac V (2010) Epigallocatechin-3-gallate (EGCG) affects the antioxidant and immune defense of the rainbow trout, Oncorhynchus mykiss. Fish Physiol Biochem 36:687–697
Tsang WP, Kwok TT (2010) Epigallocatechin gallate up-regulation of miR-16 and induction of apoptosis in human cancer cells. J Nutr Biochem 21:140–146
Tu SH, Ku CY, Ho CT, Chen CS, Huang CS, Lee CH, Chen LC, Pan MH, Chang HW, Chang CH, Chang YJ, Wei PL, Wu CH, Ho YS (2011) Tea polyphenol (-)-epigallocatechin-3-gallate inhibits nicotine- and estrogen-induced alpha9-nicotinic acetylcholine receptor upregulation in human breast cancer cells. Mol Nutr Food Res 55:455–466
Volate SR, Muga SJ, Issa AY, Nitcheva D, Smith T, Wargovich MJ (2009) Epigenetic modulation of the retinoid X receptor alpha by green tea in the azoxymethane-Apc Min/+ mouse model of intestinal cancer. Mol Carcinog 48:920–933
Wang ZY, Hong JY, Huang MT, Reuhl KR, Conney AH, Yang CS (1992) Inhibition of N-nitrosodiethylamine- and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced tumorigenesis in A/J mice by green tea and black tea. Cancer Res 52:1943–1947
Wang Z, Li Y, Kong D, Ahmad A, Banerjee S, Sarkar FH (2010) Cross-talk between miRNA and Notch signaling pathways in tumor development and progression. Cancer Lett 292:141–148
Wiseman SA, Balentine DA, Frei B (1997) Antioxidants in tea. Crit Rev Food Sci Nutr 37:705–718
Yamane T, Takahashi T, Kuwata K, Oya K, Inagake M, Kitao Y, Suganuma M, Fujiki H (1995) Inhibition of N-methyl-N′-nitro-N-nitrosoguanidine-induced carcinogenesis by (-)-epigallocatechin gallate in the rat glandular stomach. Cancer Res 55:2081–2084
Yang TT, Koo MW (2000) Inhibitory effect of Chinese green tea on endothelial cell-induced LDL oxidation. Atherosclerosis 148:67–73
Yang CS, Chung JY, Yang G, Chhabra SK, Lee MJ (2000) Tea and tea polyphenols in cancer prevention. J Nutr 130:472S–478S
Yang CS, Maliakal P, Meng X (2002) Inhibition of carcinogenesis by tea. Annu Rev Pharmacol Toxicol 42:25–54
Yang CS, Lambert JD, Hou Z, Ju J, Lu G, Hao X (2006a) Molecular targets for the cancer preventive activity of tea polyphenols. Mol Carcinog 45:431–435
Yang CS, Sang S, Lambert JD, Hou Z, Ju J, Lu G (2006b) Possible mechanisms of the cancer-preventive activities of green tea. Mol Nutr Food Res 50:170–175
Yang SP, Wilson K, Kawa A, Raner GM (2006c) Effects of green tea extracts on gene expression in HepG2 and Cal-27 cells. Food Chem Toxicol 44:1075–1081
Yang CS, Lambert JD, Ju J, Lu G, Sang S (2007) Tea and cancer prevention: molecular mechanisms and human relevance. Toxicol Appl Pharmacol 224:265–273
Yang CS, Wang X, Lu G, Picinich SC (2009) Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer 9:429–439
Yuan JM, Gao YT, Yang CS, Yu MC (2007) Urinary biomarkers of tea polyphenols and risk of colorectal cancer in the Shanghai Cohort Study. Int J Cancer 120:1344–1350
Zhang W, Weissfeld JL, Romkes M, Land SR, Grandis JR, Siegfried JM (2007) Association of the EGFR intron 1 CA repeat length with lung cancer risk. Mol Carcinog 46:372–380
Zhang Z, Stiegler AL, Boggon TJ, Kobayashi S, Halmos B (2010) EGFR-mutated lung cancer: a paradigm of molecular oncology. Oncotarget 1:497–514
Zhang CX, Wang SM, Jin HY (2011) Inhibitory effect and mechanism of (-)-epigallocatechin-3-gallate on HT29 and HCT-8 colorectal cancer cell lines and expression of HES1 and JAG1. Zhonghua Wei Chang Wai Ke Za Zhi 14:636–639
Acknowledgements
We thank our lab members for critical reading of the manuscript. This work was supported in part by the grants from the National Institutes of Health (R01CA125262, RO1CA114469 and RO1CA125262-02S1) and Kansas Bioscience Authority.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Singh, B.N., Shankar, S., Srivastava, R.K. (2012). Intracellular Signaling Network as a Prime Chemotherapy Target of Green Tea Catechin, (–)-Epigallocatechin-3-gallate. In: Shankar, S., Srivastava, R. (eds) Nutrition, Diet and Cancer. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-2923-0_15
Download citation
DOI: https://doi.org/10.1007/978-94-007-2923-0_15
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-2922-3
Online ISBN: 978-94-007-2923-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)